Cargando…

Urokinase-type Plasminogen Activator Resulting from Endometrial Carcinogenesis Enhances Tumor Invasion and Correlates with Poor Outcome of Endometrial Carcinoma Patients

The purpose of this study was to identify the dysregulated genes involved in the tumorigenesis and progression of endometrial endometrioid adenocarcinoma (EEC), and their possible mechanisms. Endometrial specimens including normal endometrial tissues, atypical endometrial hyperplasia, and EEC were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chia-Yen, Chang, Ming-Cheng, Huang, Wei-Yun, Huang, Ching-Ting, Tang, Yu-Chien, Huang, Hsien-Da, Kuo, Kuan-Ting, Chen, Chi-An, Cheng, Wen-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451531/ https://www.ncbi.nlm.nih.gov/pubmed/26033187 http://dx.doi.org/10.1038/srep10680

Ejemplares similares

Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes
por: Yeh, Chih-Chang, et al.
Publicado: (2013)

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer
por: Huang, Hsin-Hui, et al.
Publicado: (2018)

Haloperidol Instigates Endometrial Carcinogenesis and Cancer Progression by the NF-κB/CSF-1 Signaling Cascade
por: Chiang, Jung-Ying, et al.
Publicado: (2022)

Fisetin Inhibits Migration and Invasion of Human Cervical Cancer Cells by Down-Regulating Urokinase Plasminogen Activator Expression through Suppressing the p38 MAPK-Dependent NF-κB Signaling Pathway
por: Chou, Ruey-Hwang, et al.
Publicado: (2013)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

Effects of Tamoxifen on Endometrial Carcinogenesis in Mice
por: Niwa, Kenji, et al.
Publicado: (1998)

Gene Promoter Methylation in Endometrial Carcinogenesis
por: Cornel, Karlijn M. C., et al.
Publicado: (2018)

Spectroscopic evaluation of carcinogenesis in endometrial cancer
por: Depciuch, Joanna, et al.
Publicado: (2021)

The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
por: Huang, Fei, et al.
Publicado: (2020)

Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer that is Associated with Poor Outcomes in Endometrial Carcinoma
por: Lai, Yu-Ju, et al.
Publicado: (2019)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
por: Kromann-Hansen, Tobias, et al.
Publicado: (2017)

Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
por: Wong, Oscar Gee-Wan, et al.
Publicado: (2010)

An Elongated Endometrial Polyp Prolapsing Through the Introitus in a Virgin
por: Temtanakitpaisan, Teerayut, et al.
Publicado: (2018)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
por: Wu, Chung-Ze, et al.
Publicado: (2021)

Urokinase-type plasminogen activator: a new target for male contraception?
por: Qin, Ying, et al.
Publicado: (2015)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

The Significance of miR-34a Expression in Endometrial Carcinogenesis: Correlation With Expression of p16 and Ki-67 Proteins in Endometrial Cancers
por: Choi, Yoon Sung, et al.
Publicado: (2015)

DRG Neurons Promote Perineural Invasion of Endometrial Cancer via GluR2
por: Ni, Ting, et al.
Publicado: (2020)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis
por: Chiu, Hsiao-Chen, et al.
Publicado: (2019)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

The Role of LEF1 in Endometrial Gland Formation and Carcinogenesis
por: Shelton, Dawne N., et al.
Publicado: (2012)

Small non-coding RNA deregulation in endometrial carcinogenesis
por: Ravo, Maria, et al.
Publicado: (2015)

Inhibitory Effects of Medroxyprogesterone Acetate on Mouse Endometrial Carcinogenesis
por: Niwa, Kenji, et al.
Publicado: (1995)

The correlation between APOE expression and the clinical characteristics and prognosis of patients with endometrial cancer
por: Wu, Chaoying, et al.
Publicado: (2022)

Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer
por: Abbink, Karin, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients
por: Huang, Yuli, et al.
Publicado: (2017)

Urokinase-type plasminogen activator (uPA) regulates invasion and matrix remodelling in colorectal cancer
por: Micalet, Auxtine, et al.
Publicado: (2023)

A specific plasminogen activator inhibitor‐1 antagonist derived from inactivated urokinase
por: Gong, Lihu, et al.
Publicado: (2016)

Endometrial Cytology in Diagnosis of Endometrial Cancer: A Systematic Review and Meta-Analysis of Diagnostic Accuracy
por: Wang, Ting, et al.
Publicado: (2023)

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients
por: Taubert, H, et al.
Publicado: (2010)

Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndrome
por: Wu, Xiao-ling, et al.
Publicado: (2013)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4a6mllq6nq0uvgokef8bqelfv5